Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro DiagnosticsBiotechnology Equipment

PUBLISHER: Grand View Research | PRODUCT CODE: 1771576

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1771576

Molecular Diagnostics For STD Market Size, Share & Trends Analysis Report By Product, By Application, By Technology, By Region, And Segment Forecasts, 2025 - 2033

PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Molecular Diagnostics For STD Market Summary

The global molecular diagnostics for sexually transmitted diseases (STDs) market size was estimated at USD 3.36 billion in 2024 and is projected to reach USD 6.94 billion by 2030, growing at a CAGR of 8.35% from 2025 to 2033. The increasing incidence of sexually transmitted infections such as chlamydia, gonorrhea, syphilis, and human papillomavirus (HPV) is a key factor driving market growth.

The demand for accurate and early detection contributes to the uptake of molecular diagnostic tools. Improvements in nucleic acid amplification technologies and growing awareness about regular STD screening are also supporting market expansion. Supporting this trend, diagnostic developers are concentrating on next-generation molecular tests that offer rapid, multiplexed, and high-throughput detection of sexually transmitted pathogens. Recent innovations include point-of-care nucleic acid amplification tests and portable PCR-based devices designed to deliver accurate results in minimal time. For instance, in March 2025, Visby Medical received U.S. Food and Drug Administration (FDA) De Novo authorization for its Women's Sexual Health Test, the first over-the-counter PCR diagnostic device approved for at-home use. This palm-sized device enables rapid, reliable testing for chlamydia, gonorrhea, and trichomoniasis, providing results within 30 minutes without needing laboratory processing. Such advancements reflect the market's focus on expanding access to reliable testing, reducing diagnostic turnaround time, and enhancing patient management through early and precise detection.

Moreover, technological progress in molecular diagnostic research has enabled the development of more sensitive, specific, and targeted tests for sexually transmitted infections. Innovations in assay design, sample processing, and amplification techniques have improved diagnostic accuracy and reduced false negatives, crucial for effective disease management. These advancements help address existing challenges in detecting asymptomatic infections and co-infections, especially in high-risk populations. In addition, continued investment in research by diagnostic manufacturers and public health organizations supports the expansion of molecular diagnostics pipelines and promotes wider availability across diverse healthcare settings.

Despite ongoing progress, the molecular diagnostics for STD market faces several challenges that may limit growth. The development, validation, and regulatory approval of new molecular tests require substantial time and resources, with manufacturers needing to comply with rigorous safety and performance standards. These factors often cause delays in product launches and restrict market availability. In addition, ensuring consistent access to diagnostic technologies presents logistical difficulties, especially in regions with limited healthcare infrastructure. The need for reliable sample storage, transportation, and skilled personnel complicates test deployment in remote or underserved areas. These challenges highlight the necessity for coordinated efforts to address regulatory hurdles and improve distribution networks to expand access to molecular diagnostics for STDs worldwide.

Global Molecular Diagnostics For STDs Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global molecular diagnostics for sexually transmitted diseases (STDs) market report based on product, application, technology, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments & Services
  • Consumables (Reagents and kits)
  • Softwares
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • CT/NG Testing
  • Syphilis Testing
  • Gonorrhea Testing
  • HSV Testing
  • HPV Testing
  • HIV Testing
  • Trichomonas
  • Ureaplasma + Mycoplasma
  • Others
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Laboratory Testing
    • Commercial/Private Labs
    • Public Health Labs
  • PoC testing
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68040-619-4

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market: Product Movement Analysis, 2024 & 2033 (USD Million)
  • 4.3. Instruments & Services
    • 4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Consumables (Reagents and kits)
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Software
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market: Application Movement Analysis, 2024 & 2033 (USD Million)
  • 5.3. CT/NG testing
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Syphilis testing
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Gonorrhea testing
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. HSV testing
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. HPV testing
    • 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. HIV testing
    • 5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Trichomonas
    • 5.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.10. Ureaplasma + Mycoplasma
    • 5.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.11. Others
    • 5.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market: Technology Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market: Technology Movement Analysis, 2024 & 2033 (USD Million)
  • 6.3. Laboratory Testing
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. Commercial/Private Labs
      • 6.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Public Health Labs
      • 6.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. PoC testing
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market: Regional Estimates & Trend Analysis

  • 7.1. Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Share, By Region, 2024 & 2033, USD Million
  • 7.2. North America
    • 7.2.1. North America Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. China Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Australia Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. South Korea Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. South Africa Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Molecular Diagnostics for Sexually Transmitted Diseases (STDs) Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. BD
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. F. Hoffmann-La Roche Ltd
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Hologic Inc.
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Abbott
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Cepheid (Danaher)
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Qiagen
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. OraSure Technologies, Inc.
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Bio-Rad Laboratories, Inc.
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. bioMerieux SA
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Thermo Fisher Scientific, Inc.
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives
    • 8.4.11. Seegene Inc.
      • 8.4.11.1. Participant's Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Recent Developments/ Strategic Initiatives
    • 8.4.12. DiaSorin S.p.A
      • 8.4.12.1. Participant's Overview
      • 8.4.12.2. Financial Performance
      • 8.4.12.3. Product Benchmarking
      • 8.4.12.4. Recent Developments/ Strategic Initiatives
Show more
Product Code: GVR-4-68040-619-4

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 5 Global Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 6 Global Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 7 North America Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Country, 2021 - 2033 (USD Million)
  • Table 8 North America Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 9 North America Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 10 North America Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 11 U.S. Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 12 U.S. Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 13 U.S. Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 14 Canada Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 15 Canada Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 16 Canada Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 17 Mexico Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 18 Mexico Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 19 Mexico Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 20 Europe Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Country, 2021 - 2033 (USD Million)
  • Table 21 Europe Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 22 Europe Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 23 Europe Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 24 Germany Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 25 Germany Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 26 Germany Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 27 UK Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 28 UK Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 29 UK Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 30 France Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 31 France Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 32 France Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 33 Italy Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 34 Italy Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 35 Italy Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 36 Spain Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 37 Spain Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 38 Spain Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 39 Denmark Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 40 Denmark Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 41 Denmark Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 42 Sweden Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 43 Sweden Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 44 Sweden Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 45 Norway Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 46 Norway Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 47 Norway Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 52 Japan Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 53 Japan Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 54 Japan Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 55 China Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 56 China Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 57 China Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 58 India Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 59 India Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 60 India Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 61 South Korea Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 62 South Korea Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 63 South Korea Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 64 Australia Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 65 Australia Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 66 Australia Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 67 Thailand Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 68 Thailand Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 69 Thailand Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 70 Latin America Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Country, 2021 - 2033 (USD Million)
  • Table 71 Latin America Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 72 Latin America Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 73 Latin America Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 74 Brazil Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 75 Brazil Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 76 Brazil Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 77 Argentina Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 78 Argentina Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 79 Argentina Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Country, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 83 Middle East & Africa Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 85 Saudi Arabia Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 87 South Africa Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 88 South Africa Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 89 South Africa Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 90 UAE Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 91 UAE Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 92 UAE Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Product, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Application, 2021 - 2033 (USD Million)
  • Table 95 Kuwait Molecular diagnostics for Sexually Transmitted Diseases (STDs) Market, By Technology, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Molecular diagnostics for Sexually Transmitted Diseases (STDs) market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Molecular diagnostics for Sexually Transmitted Diseases (STDs) market: Product outlook key takeaways
  • Fig. 20 Molecular diagnostics for Sexually Transmitted Diseases (STDs) market: Product movement analysis
  • Fig. 21 Instruments & Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Consumables (Reagents and kits) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Softwares market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Molecular diagnostics for Sexually Transmitted Diseases (STDs) market: Application outlook key takeaways
  • Fig. 25 Molecular diagnostics for Sexually Transmitted Diseases (STDs) market: Application movement analysis
  • Fig. 26 CT/NG testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Syphilis testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Gonorrhea testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 HSV testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 HPV testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 HIV testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Trichomonas market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Ureaplasma + Mycoplasma market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Molecular diagnostics for Sexually Transmitted Diseases (STDs) market: Technology outlook key takeaways
  • Fig. 36 Molecular diagnostics for Sexually Transmitted Diseases (STDs) market: Technology movement analysis
  • Fig. 37 Laboratory Testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Commercial/Private Labs market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Public Health Labs market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 PoC testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Regional marketplace outlook, 2024 & 2033 (USD million)
  • Fig. 42 Regional marketplace: Key takeaways
  • Fig. 43 North America
  • Fig. 44 North America market estimates and forecasts, 2021 - 2033
  • Fig. 45 U.S.
  • Fig. 46 U.S. market estimates and forecasts, 2021 - 2033
  • Fig. 47 Canada
  • Fig. 48 Canada market estimates and forecasts, 2021 - 2033
  • Fig. 49 Mexico
  • Fig. 50 Mexico market estimates and forecasts, 2021 - 2033
  • Fig. 51 Europe
  • Fig. 52 Europe market estimates and forecasts, 2021 - 2033
  • Fig. 53 UK
  • Fig. 54 UK market estimates and forecasts, 2021 - 2033
  • Fig. 55 Germany
  • Fig. 56 Germany market estimates and forecasts, 2021 - 2033
  • Fig. 57 France
  • Fig. 58 France market estimates and forecasts, 2021 - 2033
  • Fig. 59 Italy
  • Fig. 60 Italy market estimates and forecasts, 2021 - 2033
  • Fig. 61 Spain
  • Fig. 62 Spain market estimates and forecasts, 2021 - 2033
  • Fig. 63 Denmark
  • Fig. 64 Denmark market estimates and forecasts, 2021 - 2033
  • Fig. 65 Sweden
  • Fig. 66 Sweden market estimates and forecasts, 2021 - 2033
  • Fig. 67 Norway
  • Fig. 68 Norway market estimates and forecasts, 2021 - 2033
  • Fig. 69 Asia Pacific
  • Fig. 70 Asia Pacific market estimates and forecasts, 2021 - 2033
  • Fig. 71 China
  • Fig. 72 China market estimates and forecasts, 2021 - 2033
  • Fig. 73 Japan
  • Fig. 74 Japan market estimates and forecasts, 2021 - 2033
  • Fig. 75 India
  • Fig. 76 India market estimates and forecasts, 2021 - 2033
  • Fig. 77 Thailand
  • Fig. 78 Thailand market estimates and forecasts, 2021 - 2033
  • Fig. 79 South Korea
  • Fig. 80 South Korea market estimates and forecasts, 2021 - 2033
  • Fig. 81 Australia
  • Fig. 82 Australia market estimates and forecasts, 2021 - 2033
  • Fig. 83 Latin America
  • Fig. 84 Latin America market estimates and forecasts, 2021 - 2033
  • Fig. 85 Brazil
  • Fig. 86 Brazil market estimates and forecasts, 2021 - 2033
  • Fig. 87 Argentina
  • Fig. 88 Argentina market estimates and forecasts, 2021 - 2033
  • Fig. 89 Middle East and Africa
  • Fig. 90 Middle East and Africa market estimates and forecasts, 2021 - 2033
  • Fig. 91 South Africa
  • Fig. 92 South Africa market estimates and forecasts, 2021 - 2033
  • Fig. 93 Saudi Arabia
  • Fig. 94 Saudi Arabia market estimates and forecasts, 2021 - 2033
  • Fig. 95 UAE
  • Fig. 96 UAE market estimates and forecasts, 2021 - 2033
  • Fig. 97 Kuwait
  • Fig. 98 Kuwait market estimates and forecasts, 2021 - 2033
  • Fig. 99 Market share of key market players-
  • Fig. 100 Market participant categorization
  • Fig. 101 Molecular diagnostics for Sexually Transmitted Diseases (STDs) market position analysis, 2024
  • Fig. 102 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!